166 related articles for article (PubMed ID: 38661126)
21. Transcription factor RFX7 governs a tumor suppressor network in response to p53 and stress.
Coronel L; Riege K; Schwab K; Förste S; Häckes D; Semerau L; Bernhart SH; Siebert R; Hoffmann S; Fischer M
Nucleic Acids Res; 2021 Jul; 49(13):7437-7456. PubMed ID: 34197623
[TBL] [Abstract][Full Text] [Related]
22. The role of DNA damage responses in p53 biology.
Speidel D
Arch Toxicol; 2015 Apr; 89(4):501-17. PubMed ID: 25618545
[TBL] [Abstract][Full Text] [Related]
23. Understanding p53 tumour suppressor network.
Panatta E; Zampieri C; Melino G; Amelio I
Biol Direct; 2021 Aug; 16(1):14. PubMed ID: 34362419
[TBL] [Abstract][Full Text] [Related]
24. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
25. Tumour suppression by p53: the importance of apoptosis and cellular senescence.
Zuckerman V; Wolyniec K; Sionov RV; Haupt S; Haupt Y
J Pathol; 2009 Sep; 219(1):3-15. PubMed ID: 19562738
[TBL] [Abstract][Full Text] [Related]
26. Tumor suppressor p53 and its mutants in cancer metabolism.
Liu J; Zhang C; Hu W; Feng Z
Cancer Lett; 2015 Jan; 356(2 Pt A):197-203. PubMed ID: 24374014
[TBL] [Abstract][Full Text] [Related]
27. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses.
Ou Y; Wang SJ; Li D; Chu B; Gu W
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6806-E6812. PubMed ID: 27698118
[TBL] [Abstract][Full Text] [Related]
28. The mitochondrial p53 pathway.
Vaseva AV; Moll UM
Biochim Biophys Acta; 2009 May; 1787(5):414-20. PubMed ID: 19007744
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.
Schlereth K; Heyl C; Krampitz AM; Mernberger M; Finkernagel F; Scharfe M; Jarek M; Leich E; Rosenwald A; Stiewe T
PLoS Genet; 2013; 9(8):e1003726. PubMed ID: 23966881
[TBL] [Abstract][Full Text] [Related]
30. A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications.
Wang M; Attardi LD
Annu Rev Pathol; 2022 Jan; 17():205-226. PubMed ID: 34699262
[No Abstract] [Full Text] [Related]
31. Systems analysis of ATF3 in stress response and cancer reveals opposing effects on pro-apoptotic genes in p53 pathway.
Tanaka Y; Nakamura A; Morioka MS; Inoue S; Tamamori-Adachi M; Yamada K; Taketani K; Kawauchi J; Tanaka-Okamoto M; Miyoshi J; Tanaka H; Kitajima S
PLoS One; 2011; 6(10):e26848. PubMed ID: 22046379
[TBL] [Abstract][Full Text] [Related]
32. PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53/p63 effector PERP.
Roberts O; Paraoan L
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188393. PubMed ID: 32679166
[TBL] [Abstract][Full Text] [Related]
33. Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents.
Carlsen L; El-Deiry WS
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769259
[TBL] [Abstract][Full Text] [Related]
34. CKIα ablation highlights a critical role for p53 in invasiveness control.
Elyada E; Pribluda A; Goldstein RE; Morgenstern Y; Brachya G; Cojocaru G; Snir-Alkalay I; Burstain I; Haffner-Krausz R; Jung S; Wiener Z; Alitalo K; Oren M; Pikarsky E; Ben-Neriah Y
Nature; 2011 Feb; 470(7334):409-13. PubMed ID: 21331045
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor p53 and its gain-of-function mutants in cancer.
Liu J; Zhang C; Feng Z
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):170-9. PubMed ID: 24374774
[TBL] [Abstract][Full Text] [Related]
36. An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression.
Indeglia A; Leung JC; Miller SA; Leu JI; Dougherty JF; Clarke NL; Kirven NA; Shao C; Ke L; Lovell S; Barnoud T; Lu DY; Lin C; Kannan T; Battaile KP; Yang THL; Batista Oliva I; Claiborne DT; Vogel P; Liu L; Liu Q; Nefedova Y; Cassel J; Auslander N; Kossenkov AV; Karanicolas J; Murphy ME
Cancer Discov; 2023 Jul; 13(7):1696-1719. PubMed ID: 37140445
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppressive functions of p53.
Zilfou JT; Lowe SW
Cold Spring Harb Perspect Biol; 2009 Nov; 1(5):a001883. PubMed ID: 20066118
[TBL] [Abstract][Full Text] [Related]
38. p53-Related Transcription Targets of TAp73 in Cancer Cells-Bona Fide or Distorted Reality?
Wang C; Teo CR; Sabapathy K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079264
[TBL] [Abstract][Full Text] [Related]
39. PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis.
Gnanapradeepan K; Indeglia A; Stieg DC; Clarke N; Shao C; Dougherty JF; Murali N; Murphy ME
J Biol Chem; 2022 Dec; 298(12):102637. PubMed ID: 36309086
[TBL] [Abstract][Full Text] [Related]
40. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK
J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
